Dr. Ramesh Subramani, MD

Dr. Subramani practices at Scripps Memorial Hospital Encinitas in Encinitas, California, part of Scripps Health.

Dr. Subramani's NPI, 1306982319, was assigned on January 29, 2007. Dr. Subramani graduated from Feinberg School of Medicine in 1995. Dr. Subramani holds California license A83096.

Dr. Subramani's primary practice is Scripps Memorial Hospital Encinitas, at 354 Santa Fe Drive, Encinitas, CA 92024 in San Diego County. The practice phone is (760) 753-6501.

Dr. Subramani's primary practice is Scripps Memorial Hospital Encinitas in Encinitas, California, part of Scripps Health. The medical group on file is Encinitas Emergency Medicine. Dmand AI also links Dr. Subramani to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Subramani practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Subramani's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Subramani is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Subramani's licenses on file in 11 states: California, Texas, Arizona, Illinois, Nevada, New York, Hawaii, Missouri, Maryland, District of Columbia and Virginia.

CMS data shows 1,859 Medicare services from Dr. Subramani across 18 procedure codes in 2024, for 776 Medicare patients. Medicare paid $112,119 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 776 Medicare patients who saw Dr. Subramani in 2024. The largest group is 75 to 84, with 318 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Subramani's median patient age at 64, with 57% women.

In 2024, Dr. Subramani wrote 366 Medicare Part D claims for 237 patients. 95% of them were for generic drugs. CMS names the drug for 176 of them, across 8 drugs with 11 or more claims each, at $1,136 in total drug cost. In 2023, CMS named 207 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Subramani for performance year 2024, reported as part of a group. Dr. Subramani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Subramani, published from 2005 to 2012. The most frequent topics are India, Tuberculosis and Directly Observed Therapy. Dr. Subramani has published most often in Int J Tuberc Lung Dis. Dr. Subramani's most frequent co-authors are Suhas Radhakrishna, MD and Farhad Navab, MD.

Dr. Subramani graduated from Feinberg School of Medicine in 1995.

Dr. Subramani is in network with 9 carriers, including United Healthcare, Blue Cross Blue Shield of Massachusetts and HCSC. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.